Cirugía laparoscópica hepática y pancreática

Anales del sistema sanitario de Navarra (Impact Factor: 0.44). 01/2005; 28. DOI: 10.4321/S1137-66272005000600007
Source: OAI


El desarrollo de la cirugía laparoscópica incluye también los procedimientos más complejos de la cirugía abdominal como los que afectan al hígado y al páncreas. Desde la laparoscopia diagnóstica, acompañada de ecografía laparoscópica, hasta las resecciones mayores hepáticas o pancreáticas, el abordaje laparoscópico se ha ido extendiendo y abarca hoy la práctica totalidad de los procedimientos quirúrgicos en patología hepatopancreática. Sin olvidar nunca que el objetivo de la cirugía mínimamente invasiva no es un mejor resultado estético sino la disminución de las complicaciones postoperatorias, es innegable que el abordaje laparoscópico ha supuesto un gran beneficio para los pacientes en todo tipo de cirugías excepto, por el momento, en el caso de las grandes resecciones como la hepatectomía izquierda o derecha o las resecciones de segmentos VII y VIII. La cirugía pancreática ha tenido un gran desarrollo con la laparoscopia, especialmente en el campo de la pancreatectomía distal por tumores quísticos y neuroendocrinos, en los que el abordaje de elección es laparoscópico. Igualmente juega un importante papel la laparoscopia, junto con la ecolaparoscopia, en la estadificación de tumores pancreáticos, previa a la cirugía abierta o para indicar el tratamiento adecuado. En los próximos años, es de esperar que el desarrollo siga siendo exponencial, y, unido a los avances en robótica, permitirá asistir todavía a un mayor impacto del abordaje laparoscópico en el campo de la cirugía hepática y pancreática. Palabras clave. Laparoscopia. Cirugía mínimamente invasiva. Cirugía hepática laparoscópica. Cirugía pancreática laparoscópica. Resección laparoscópica.

Download full-text


Available from: Fernando Pardo, Oct 10, 2015
24 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: In most patients with pancreatic cancer, the tumor is unresectable. Nonoperative methods for palliation of jaundice, duodenal obstruction, and pain currently are being developed. Preoperative assessment of resectability of the tumor is becoming more and more important to avoid unnecessary operations. The aim of this study was to compare computed tomography (CT) and laparoscopy with special reference to the additive role of the latter technique in predicting unresectability of pancreatic cancers.Study Design: Sixty patients with exocrine pancreatic cancer were assessed prospectively with both CT and laparoscopy. On the basis of metastatic spread or signs of vascular involvement, the radiologist and the laparoscopist independently reported the tumors as probably unresectable or resectable.Results: The predictive value for unresectability was 100% for both CT and laparoscopy. Sensitivity in predicting unresectability was 69% for both techniques, and the corresponding figure for specificity was 100%. When CT and laparoscopy were evaluated together, an improvement in sensitivity to 87% was observed (p < 0.05). Separately, CT and laparoscopy correctly predicted resectability in only 30% and 38% of the patients, respectively. The presence of liver metastases was overlooked by CT in 13 of 32 patients (40%). Every fourth patient who was found to have unresectable tumor at CT was falsely classified as resectable by the laparoscopist, leading to unnecessary laparotomies. On the other hand, 9 of 24 patients (38%) with resectable disease at CT were deemed unresectable at the subsequent laparoscopy.Conclusions: Laparoscopy and CT independently and reliably predicted unresectability of pancreatic cancer, but the methods were inaccurate in forecasting resectability. The results suggest that CT examination should be done in patients who are candidates for attempted curative surgical procedures, whereas laparoscopy should be restricted to Those Judged resectable at CT.
    Journal of the American College of Surgeons 01/1998; 186(1-186):35-40. DOI:10.1016/S1072-7515(97)00128-2 · 5.12 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Laparoscopic pancreatic surgery should be considered as an advanced laparoscopic procedure and should be performed only in institutions with experience in pancreatic surgery by a team with advanced laparoscopic skills. This review discusses the current status of the laparoscopic approach for inflammatory pancreatic diseases and for benign-appearing pancreatic tumors. Laparoscopic surgery has been shown to be beneficial in patients with inflammatory tumors located in the body-tail of the pancreas for chronic pancreatitis. Furthermore, patients with pancreatic pseudocysts may be managed with laparoscopic internal drainage (to the stomach, duodenum, or jejunum). Also, laparoscopic or retroperitoneoscopic necrosectomy has been used with success in patients with necrotizing pancreatitis. At present, laparoscopic surgery has proven to be beneficial in patients with cystic pancreatic neoplasms and neuroendocrine pancreatic tumors. The laparoscopic pancreatic approach was recently shown to be feasible and safe. Laparoscopy may contribute to reduced operation time and perioperative blood loss, and reduces surgical stress because of developments in devices, improvements in procedures, and advanced techniques.
    Langenbeck s Archives of Surgery 09/2005; 390(4):342-54. DOI:10.1007/s00423-005-0556-5 · 2.19 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This prospective, randomized, single-institution trial was designed to evaluate the role of prophylactic gastrojejunostomy in patients found at exploratory laparotomy to have unresectable periampullary carcinoma. Between 25% and 75% of patients with periampullary cancer who undergo exploratory surgery with intent to perform a pancreaticoduodenectomy are found to have unresectable disease. Most will undergo a biliary-enteric bypass. Whether or not to perform a prophylactic gastrojejunostomy remains unresolved. Retrospective reviews of surgical series and prospective randomized trials of endoscopic palliation have demonstrated that late gastric outlet obstruction, requiring a gastrojejunostomy, develops in 10% to 20% of patients with unresectable periampullary cancer. Between May 1994 and October 1998, 194 patients with a periampullary malignancy underwent exploratory surgery with the purpose of performing a pancreaticoduodenectomy and were found to have unresectable disease. On the basis of preoperative symptoms, radiologic studies, or surgical findings, the surgeon determined that gastric outlet obstruction was a significant risk in 107 and performed a gastrojejunostomy. The remaining 87 patients were thought by the surgeon not to be at significant risk for duodenal obstruction and were randomized to receive either a prophylactic retrocolic gastrojejunostomy or no gastrojejunostomy. Short- and long-term outcomes were determined in all patients. Of the 87 patients randomized, 44 patients underwent a retrocolic gastrojejunostomy and 43 did not undergo a gastric bypass. The two groups were similar with respect to age, gender, procedure performed (excluding gastrojejunostomy), and surgical findings. There were no postoperative deaths in either group, and the postoperative morbidity rates were comparable (gastrojejunostomy 32%, no gastrojejunostomy 33%). The postoperative length of stay was 8.5+/-0.5 days for the gastrojejunostomy group and 8.0+/-0.5 days for the no gastrojejunostomy group. Mean survival among those who received a prophylactic gastrojejunostomy was 8.3 months, and during that interval gastric outlet obstruction developed in none of the 44 patients. Mean survival among those who did not have a prophylactic gastrojejunostomy was 8.3 months. In 8 of those 43 patients (19%), late gastric outlet obstruction developed, requiring therapeutic intervention (gastrojejunostomy 7 patients, endoscopic duodenal stent 1 patient; p < 0.01). The median time between initial exploration and therapeutic intervention was 2 months. The results from this prospective, randomized trial demonstrate that prophylactic gastrojejunostomy significantly decreases the incidence of late gastric outlet obstruction. The performance of a prophylactic retrocolic gastrojejunostomy at the initial surgical procedure does not increase the incidence of postoperative complications or extend the length of stay. A retrocolic gastrojejunostomy should be performed routinely when a patient is undergoing surgical palliation for unresectable periampullary carcinoma.
    Annals of Surgery 10/1999; 230(3):322-8; discussion 328-30. DOI:10.1097/00000658-199909000-00005 · 8.33 Impact Factor
Show more